{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:10:51Z","timestamp":1789949451651,"version":"4.0.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,18]],"date-time":"2015-01-18T00:00:00Z","timestamp":1421539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,1,18]],"date-time":"2015-01-18T00:00:00Z","timestamp":1421539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s12013-014-0434-2","type":"journal-article","created":{"date-parts":[[2015,1,17]],"date-time":"2015-01-17T05:04:42Z","timestamp":1421471082000},"page":"179-183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["HIF-\u03b1 Promotes Chronic Myelogenous Leukemia Cell Proliferation by Upregulating p21 Expression"],"prefix":"10.1007","volume":"72","author":[{"given":"Heng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ri","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,18]]},"reference":[{"key":"434_CR1","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nm1005-1047","volume":"11","author":"MA Esteban","year":"2005","unstructured":"Esteban, M. A., & Maxwell, P. H. (2005). HIF, a missing link between metabolism and cancer. Nature Medicine,\n                  11, 1047\u20131048.","journal-title":"Nature Medicine"},{"key":"434_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1172\/JCI118437","volume":"97","author":"E Brogi","year":"1996","unstructured":"Brogi, E., Schatteman, G., Wu, T., Kim, E. A., Varticovski, L., Keyt, B., & Isner, J. M. (1996). Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. Journal of Clinical Investigation,\n                  97, 469\u2013476.","journal-title":"Journal of Clinical Investigation"},{"key":"434_CR3","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/S0360-3016(02)03935-4","volume":"54","author":"HL Janssen","year":"2002","unstructured":"Janssen, H. L., Haustermans, K. M., Sprong, D., Blommestijn, G., Hofland, I., Hoebers, F. J., et al. (2002). HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors. International Journal of Radiation Oncology Biology Physics,\n                  54, 1537\u20131549.","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"key":"434_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/cancers5010015","volume":"5","author":"Y Kitajima","year":"2013","unstructured":"Kitajima, Y., & Miyazaki, K. (2013). The critical impact of HIF-1a on gastric cancer biology. Cancers (Basel),\n                  5, 15\u201326.","journal-title":"Cancers (Basel)"},{"key":"434_CR5","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1161\/01.RES.0000102937.50486.1B","volume":"93","author":"BD Kelly","year":"2003","unstructured":"Kelly, B. D., Hackett, S. F., Hirota, K., Oshima, Y., Cai, Z., Berg-Dixon, S., et al. (2003). Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circulation Research,\n                  93, 1074\u20131081.","journal-title":"Circulation Research"},{"key":"434_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4161\/cbt.9.4.10744","volume":"9","author":"JH Huang","year":"2010","unstructured":"Huang, J. H., Lee, F. S., Pasha, T. L., Sammel, M. D., Karakousis, G., Xu, G., et al. (2010). Analysis of HIF-1a and its regulator, PHD2, in retroperitoneal sarcomas: Clinico-pathologic implications. Cancer Biology & Therapy,\n                  9, 303\u2013311.","journal-title":"Cancer Biology & Therapy"},{"key":"434_CR7","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1182\/blood-2010-09-307538","volume":"117","author":"SS Oladipupo","year":"2011","unstructured":"Oladipupo, S. S., Hu, S., Santeford, A. C., Yao, J., Kovalski, J. R., Shohet, R. V., et al. (2011). Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence. Blood,\n                  117, 4142\u20134153.","journal-title":"Blood"},{"key":"434_CR8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/ncb1534","volume":"9","author":"A Kaidi","year":"2007","unstructured":"Kaidi, A., Williams, A. C., & Paraskeva, C. (2007). Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nature Cell Biology,\n                  9, 210\u2013217.","journal-title":"Nature Cell Biology"},{"key":"434_CR9","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1182\/blood-2011-12-396226","volume":"119","author":"JC Chomel","year":"2012","unstructured":"Chomel, J. C., Sorel, N., Guilhot, J., Guilhot, F., & Turhan, A. G. (2012). BCR-ABL expression in leukemic progenitors and primitive stem cells of patients with chronic myeloid leukemia. Blood,\n                  119, 2964\u20132965. author reply 2965\u20132966.","journal-title":"Blood"},{"key":"434_CR10","doi-asserted-by":"publisher","first-page":"14073","DOI":"10.1074\/jbc.M700732200","volume":"282","author":"Y Makino","year":"2007","unstructured":"Makino, Y., Uenishi, R., Okamoto, K., Isoe, T., Hosono, O., Tanaka, H., et al. (2007). Transcriptional up-regulation of inhibitory PAS domain protein gene expression by hypoxia-inducible factor 1 (HIF-1): A negative feedback regulatory circuit in HIF-1-mediated signaling in hypoxic cells. Journal of Biological Chemistry,\n                  282, 14073\u201314082.","journal-title":"Journal of Biological Chemistry"},{"key":"434_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ctrv.2006.05.003","volume":"32","author":"JL O\u2019Donnell","year":"2006","unstructured":"O\u2019Donnell, J. L., Joyce, M. R., Shannon, A. M., Harmey, J., Geraghty, J., & Bouchier-Hayes, D. (2006). Oncological implications of hypoxia inducible factor-1alpha (HIF-1alpha) expression. Cancer Treatment Reviews,\n                  32, 407\u2013416.","journal-title":"Cancer Treatment Reviews"},{"key":"434_CR12","doi-asserted-by":"publisher","first-page":"6123","DOI":"10.1038\/sj.onc.1209643","volume":"25","author":"EH Gort","year":"2006","unstructured":"Gort, E. H., Groot, A. J., Derks van de Ven, T. L., van der Groep, P., Verlaan, I., van Laar, T., et al. (2006). Hypoxia-inducible factor-1alpha expression requires PI 3-kinase activity and correlates with Akt1 phosphorylation in invasive breast carcinomas. Oncogene,\n                  25, 6123\u20136127.","journal-title":"Oncogene"},{"key":"434_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cca.2007.12.005","volume":"389","author":"JY Lee","year":"2008","unstructured":"Lee, J. Y., Choi, J. Y., Lee, K. M., Park, S. K., Han, S. H., Noh, D. Y., et al. (2008). Rare variant of hypoxia-inducible factor-1alpha (HIF-1A) and breast cancer risk in Korean women. Clinica Chimica Acta,\n                  389, 167\u2013170.","journal-title":"Clinica Chimica Acta"},{"key":"434_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/bies.20002","volume":"26","author":"JI Bardos","year":"2004","unstructured":"Bardos, J. I., & Ashcroft, M. (2004). Hypoxia-inducible factor-1 and oncogenic signalling. BioEssays,\n                  26, 262\u2013269.","journal-title":"BioEssays"},{"key":"434_CR15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3748\/wjg.v9.i3.491","volume":"9","author":"YA Jiang","year":"2003","unstructured":"Jiang, Y. A., Fan, L. F., Jiang, C. Q., Zhang, Y. Y., Luo, H. S., Tang, Z. J., et al. (2003). Expression and significance of PTEN, hypoxia-inducible factor-1 alpha in colorectal adenoma and adenocarcinoma. World Journal of Gastroenterology,\n                  9, 491\u2013494.","journal-title":"World Journal of Gastroenterology"},{"key":"434_CR16","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/path.3001","volume":"226","author":"A Nakatsuka","year":"2012","unstructured":"Nakatsuka, A., Wada, J., Hida, K., Hida, A., Eguchi, J., Teshigawara, S., et al. (2012). RXR antagonism induces G0\/G1 cell cycle arrest and ameliorates obesity by up-regulating the p53-p21(Cip1) pathway in adipocytes. Journal of Pathology,\n                  226, 784\u2013795.","journal-title":"Journal of Pathology"},{"key":"434_CR17","doi-asserted-by":"publisher","first-page":"e34303","DOI":"10.1371\/journal.pone.0034303","volume":"7","author":"X Yang","year":"2012","unstructured":"Yang, X., Wang, W., Qin, J. J., Wang, M. H., Sharma, H., Buolamwini, J. K., et al. (2012). JKA97, a novel benzylidene analog of harmine, exerts anti-cancer effects by inducing G1 arrest, apoptosis, and p53-independent up-regulation of p21. PLoS One,\n                  7, e34303.","journal-title":"PLoS One"},{"key":"434_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/1471-2407-13-167","volume":"13","author":"G Wu","year":"2013","unstructured":"Wu, G., Lin, N., Xu, L., Liu, B., & Feitelson, M. A. (2013). UCN-01 induces S and G2\/M cell cycle arrest through the p53\/p21(waf1) or CHK2\/CDC25C pathways and can suppress invasion in human hepatoma cell lines. BMC Cancer,\n                  13, 167.","journal-title":"BMC Cancer"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-014-0434-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12013-014-0434-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-014-0434-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-014-0434-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T18:41:34Z","timestamp":1602268894000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12013-014-0434-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,18]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["434"],"URL":"https:\/\/doi.org\/10.1007\/s12013-014-0434-2","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,18]]},"assertion":[{"value":"18 January 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}